# Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting

Study · id `cardio:ct-nct02351050` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02351050](<https://clinicaltrials.gov/study/NCT02351050>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02351050

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 144 participants.

## Technical summary

Registry record NCT02351050. Randomized; single masking; primary purpose prevention. Start 2015-04 (actual); primary completion 2017-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 144 participants (enrolled count; ClinicalTrials.gov record NCT02351050, source copy `cardio:ctgov-nct02351050-2018-03-26`, retrieved 2026-10-26)
- Started: 2015-04 (actual) (ClinicalTrials.gov record NCT02351050, source copy `cardio:ctgov-nct02351050-2018-03-26`, retrieved 2026-10-26)
- Primary completion: 2017-09 (actual) (ClinicalTrials.gov record NCT02351050, source copy `cardio:ctgov-nct02351050-2018-03-26`, retrieved 2026-10-26)
- Completion: 2017-11 (actual) (ClinicalTrials.gov record NCT02351050, source copy `cardio:ctgov-nct02351050-2018-03-26`, retrieved 2026-10-26)
- Countries: Slovakia (ClinicalTrials.gov record NCT02351050, source copy `cardio:ctgov-nct02351050-2018-03-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02351050-2018-03-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting
- Condition: Coronary Artery Disease
- Intervention (Device): Sonolysis
- Intervention (Other): Sham procedure
- Lead sponsor: University Hospital Ostrava
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University Hospital Ostrava (`cardio:org-university-hospital-ostrava`)

## Provenance

Content hash: 9fe18316283db17d1e7394ac457cf042ec898c270f9c3164271e95cc725dffd0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
